NYSE:MED - Medifast Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$217.51 +6.41 (+3.04 %)
(As of 08/20/2018 04:00 PM ET)
Previous Close$211.10
Today's Range$211.53 - $218.00
52-Week Range$54.06 - $229.20
Volume176,200 shs
Average Volume181,082 shs
Market Capitalization$2.45 billion
P/E Ratio92.72
Dividend Yield0.91%
Beta0.28
Medifast logoMedifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, medical professionals, franchise weight loss clinics, and direct consumer marketing. As of December 31, 2017, it operated 16 franchised Medifast weight control centers in Arizona, California, Louisiana, Minnesota, and Wisconsin; and 18 reseller locations in California, Maryland, and Pennsylvania. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples
SymbolNYSE:MED
CUSIP58470H10
Phone410-581-8042

Debt

Debt-to-Equity RatioN/A
Current Ratio2.53
Quick Ratio2.02

Price-To-Earnings

Trailing P/E Ratio92.72
Forward P/E Ratio48.34
P/E Growth2.27

Sales & Book Value

Annual Sales$301.56 million
Price / Sales8.62
Cash Flow$2.9056 per share
Price / Cash74.86
Book Value$9.10 per share
Price / Book23.90

Profitability

EPS (Most Recent Fiscal Year)$2.29
Net Income$27.72 million
Net Margins10.87%
Return on Equity37.25%
Return on Assets27.42%

Miscellaneous

Employees399
Outstanding Shares11,950,000
Market Cap$2.45 billion

Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast announced a quarterly dividend on Friday, June 15th. Investors of record on Friday, June 29th will be given a dividend of $0.48 per share on Wednesday, August 8th. This represents a $1.92 annualized dividend and a yield of 0.88%. The ex-dividend date is Thursday, June 28th. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) released its quarterly earnings data on Thursday, August, 2nd. The specialty retailer reported $1.16 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.98 by $0.18. The specialty retailer had revenue of $117.30 million for the quarter, compared to analyst estimates of $101.75 million. Medifast had a return on equity of 37.25% and a net margin of 10.87%. The company's quarterly revenue was up 55.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.63 earnings per share. View Medifast's Earnings History.

When is Medifast's next earnings date?

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, November, 6th 2018. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast updated its FY18 earnings guidance on Thursday, August, 2nd. The company provided EPS guidance of $4.35-4.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.67. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $398.16 million.Medifast also updated its Q3 guidance to $1.05-1.10 EPS.

What price target have analysts set for MED?

2 Wall Street analysts have issued 1 year target prices for Medifast's stock. Their forecasts range from $55.00 to $249.00. On average, they anticipate Medifast's stock price to reach $152.00 in the next year. This suggests that the stock has a possible downside of 30.1%. View Analyst Price Targets for Medifast.

What is the consensus analysts' recommendation for Medifast?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medifast.

Who are some of Medifast's key competitors?

Who are Medifast's key executives?

Medifast's management team includes the folowing people:
  • Mr. Daniel R. Chard, CEO & Director (Age 53)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 56)
  • Mr. Bill Baker, Exec. VP of Information Technology (Age 46)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)
  • Mr. Joseph Kelleman, VP of Fin. & Corp. Controller (Age 63)

Has Medifast been receiving favorable news coverage?

News coverage about MED stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Medifast earned a news and rumor sentiment score of 0.00 on Accern's scale. They also gave news articles about the specialty retailer an impact score of 45.96 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for Medifast.

Who are Medifast's major shareholders?

Medifast's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.90%), Renaissance Technologies LLC (8.31%), Dimensional Fund Advisors LP (5.79%), Acadian Asset Management LLC (3.76%), Bank of New York Mellon Corp (1.44%) and American Century Companies Inc. (1.20%). Company insiders that own Medifast stock include Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.

Which major investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, American Century Companies Inc., Martingale Asset Management L P, Castleark Management LLC, EAM Investors LLC, ClariVest Asset Management LLC, TD Asset Management Inc. and Bessemer Group Inc.. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling, Jeremy John Martin, Michael C Macdonald and Ralph Rushton. View Insider Buying and Selling for Medifast.

Which major investors are buying Medifast stock?

MED stock was purchased by a variety of institutional investors in the last quarter, including Intrinsic Edge Capital Management LLC, MUFG Securities EMEA plc, BlackRock Inc., Point72 Asset Management L.P., Russell Investments Group Ltd., Osterweis Capital Management Inc., Navellier & Associates Inc and BNP Paribas Arbitrage SA. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $217.51.

How big of a company is Medifast?

Medifast has a market capitalization of $2.45 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 399 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]


MarketBeat Community Rating for Medifast (NYSE MED)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  211 (Vote Outperform)
Underperform Votes:  235 (Vote Underperform)
Total Votes:  446
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel